Your browser doesn't support javascript.
loading
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders.
Pagliuca, Simona; Gurnari, Carmelo; Awada, Hassan; Kishtagari, Ashwin; Kongkiatkamon, Sunisa; Terkawi, Laila; Zawit, Misam; Guan, Yihong; LaFramboise, Thomas; Jha, Babal K; Patel, Bhumika J; Hamilton, Betty K; Majhail, Navneet S; Lundgren, Sofie; Mustjoki, Satu; Saunthararajah, Yogen; Visconte, Valeria; Chan, Timothy A; Yang, Chao-Yie; Lenz, Tobias L; Maciejewski, Jaroslaw P.
Affiliation
  • Pagliuca S; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Gurnari C; University of Paris, Paris, France.
  • Awada H; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Kishtagari A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Kongkiatkamon S; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Terkawi L; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Zawit M; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Guan Y; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • LaFramboise T; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Jha BK; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Patel BJ; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH.
  • Hamilton BK; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
  • Majhail NS; Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH.
  • Lundgren S; Blood and Marrow Transplant Program, Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH.
  • Mustjoki S; Blood and Marrow Transplant Program, Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH.
  • Saunthararajah Y; Hematology Research Unit Helsinki, University of Helsinki-Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Visconte V; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Chan TA; Hematology Research Unit Helsinki, University of Helsinki-Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Yang CY; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Lenz TL; ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Maciejewski JP; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH.
Blood ; 138(26): 2781-2798, 2021 12 30.
Article in En | MEDLINE | ID: mdl-34748628
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HLA-D Antigens / Genes, MHC Class II / Anemia, Aplastic Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HLA-D Antigens / Genes, MHC Class II / Anemia, Aplastic Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Document type: Article Country of publication: